281 related articles for article (PubMed ID: 8384496)
21. Binding of plasmin(ogen) to sepharose bound fibrin(ogen) alpha-chain.
Cederholm-Williams SA; Fennell SJ
Thromb Res; 1981 Feb 15-Mar 1; 21(4-5):503-6. PubMed ID: 6455773
[No Abstract] [Full Text] [Related]
22. Evaluation of the fibrin binding profile of two anti-fibrin monoclonal antibodies.
Raut S; Gaffney PJ
Thromb Haemost; 1996 Jul; 76(1):56-64. PubMed ID: 8819252
[TBL] [Abstract][Full Text] [Related]
23. Plasma cross-linked fibrin degradation product (XLFbDP) assays in an in vivo model of fibrinolysis.
Rowbotham BJ; Whitaker AN; Masci PP
Blood Coagul Fibrinolysis; 1990 Dec; 1(6):653-61. PubMed ID: 2133245
[TBL] [Abstract][Full Text] [Related]
24. Fibrinogen degradation by hementin, a fibrinogenolytic anticoagulant from the salivary glands of the leech Haementeria ghilianii.
Malinconico SM; Katz JB; Budzynski AZ
J Lab Clin Med; 1984 Nov; 104(5):842-54. PubMed ID: 6387015
[TBL] [Abstract][Full Text] [Related]
25. Demonstration of covalent binding of lipoprotein(a) [Lp(a)] to fibrin and endothelial cells.
Liu JN; Kung W; Harpel PC; Gurewich V
Biochemistry; 1998 Mar; 37(11):3949-54. PubMed ID: 9521716
[TBL] [Abstract][Full Text] [Related]
26. The fibrin(ogen)olytic properties of cathepsin D.
Simon DI; Ezratty AM; Loscalzo J
Biochemistry; 1994 May; 33(21):6555-63. PubMed ID: 8204591
[TBL] [Abstract][Full Text] [Related]
27. Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasmin.
Lee AY; Fredenburgh JC; Stewart RJ; Rischke JA; Weitz JI
Thromb Haemost; 2001 Mar; 85(3):502-8. PubMed ID: 11307822
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-1beta but not IL-1alpha binds to fibrinogen and fibrin and has enhanced activity in the bound form.
Sahni A; Guo M; Sahni SK; Francis CW
Blood; 2004 Jul; 104(2):409-14. PubMed ID: 15039285
[TBL] [Abstract][Full Text] [Related]
29. Noncovalent interaction of alpha(2)-antiplasmin with fibrin(ogen): localization of alpha(2)-antiplasmin-binding sites.
Tsurupa G; Yakovlev S; McKee P; Medved L
Biochemistry; 2010 Sep; 49(35):7643-51. PubMed ID: 20687529
[TBL] [Abstract][Full Text] [Related]
30. Initial interaction between fibrin and tissue plasminogen activator (t-PA). The Gly-Pro-Arg-Pro binding site on fibrin(ogen) is important for t-PA activity.
Kaczmarek E; Lee MH; McDonagh J
J Biol Chem; 1993 Feb; 268(4):2474-9. PubMed ID: 8428923
[TBL] [Abstract][Full Text] [Related]
31. Soluble crosslinked fibrin(ogen) polymers.
Selmayr E; Müller-Berghaus G
Thromb Haemost; 1985 Dec; 54(4):804-7. PubMed ID: 4089815
[TBL] [Abstract][Full Text] [Related]
32. Anion-binding exosite of human alpha-thrombin and fibrin(ogen) recognition.
Fenton JW; Olson TA; Zabinski MP; Wilner GD
Biochemistry; 1988 Sep; 27(18):7106-12. PubMed ID: 3196704
[TBL] [Abstract][Full Text] [Related]
33. The COOH-terminal globular domain of fibrinogen gamma chain suppresses angiogenesis and tumor growth.
Akakura N; Hoogland C; Takada YK; Saegusa J; Ye X; Liu FT; Cheung AT; Takada Y
Cancer Res; 2006 Oct; 66(19):9691-7. PubMed ID: 17018627
[TBL] [Abstract][Full Text] [Related]
34. Terminal plasmin degradation products D and E of duck fibrinogen and their effect on polymerization of fibrin.
Krajewski T; Nowak P; Cierniewski C
Acta Biochim Pol; 1985; 32(2):144-54. PubMed ID: 4036448
[TBL] [Abstract][Full Text] [Related]
35. Two families of synthetic peptides that enhance fibrin turbidity and delay fibrinolysis by different mechanisms.
Pandi L; Kollman JM; Lopez-Lira F; Burrows JM; Riley M; Doolittle RF
Biochemistry; 2009 Aug; 48(30):7201-8. PubMed ID: 19588915
[TBL] [Abstract][Full Text] [Related]
36. Effects of fibrin and alpha2-antiplasmin on plasminogen activation by staphylokinase.
Okada K; Ueshima S; Takaishi T; Yuasa H; Fukao H; Matsuo O
Am J Hematol; 1996 Nov; 53(3):151-7. PubMed ID: 8895684
[TBL] [Abstract][Full Text] [Related]
37. Platelet adhesion to fibrinogen, fibrin monomer, and fibrin protofibrils in flowing blood -- the effect of fibrinogen immobilization and fibrin formation.
Jirousková M; Dyr JE; Suttnar J; Holada K; Trnková B
Thromb Haemost; 1997 Sep; 78(3):1125-31. PubMed ID: 9308765
[TBL] [Abstract][Full Text] [Related]
38. Binding of a new monoclonal antibody against N-terminal heptapeptide of fibrin alpha-chain to fibrin polymerization site 'A': effects of fibrinogen and fibrinogen derivatives, and pretreatment of samples with NaSCN.
Dempfle CE; Dollman M; Lill H; Puzzovio D; Dessauer A; Heene DL
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):79-86. PubMed ID: 8457657
[TBL] [Abstract][Full Text] [Related]
39. [The antifibrinolytic action of the D-dimer fragment].
Rozenfel'd MA; Khavkina LS; Leonova VB; Gershkovich KB; Vasil'eva MV
Izv Akad Nauk SSSR Biol; 1989; (6):855-61. PubMed ID: 2621282
[TBL] [Abstract][Full Text] [Related]
40. Thrombin cleavage enhances exposure of a heparin binding domain in the N-terminus of the fibrin beta chain.
Odrljin TM; Shainoff JR; Lawrence SO; Simpson-Haidaris PJ
Blood; 1996 Sep; 88(6):2050-61. PubMed ID: 8822924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
